Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has scheduled the release of its HY26 financial results for 13 February 2026, when management will brief analysts and media via a webcast and conference call. The company will provide live access to its results presentation, including a Q&A session for registered participants, and will later make all related result documents and an archived webcast available to shareholders through its investor relations website, underscoring its focus on transparent communication with the market and key stakeholders.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$300.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is an Australian medical device company specialising in implantable hearing solutions, including cochlear implants and related technologies, serving patients with moderate to profound hearing loss and operating globally in the hearing health market.
YTD Price Performance: 3.01%
Average Trading Volume: 118,295
Technical Sentiment Signal: Hold
Current Market Cap: A$17.56B
Find detailed analytics on COH stock on TipRanks’ Stock Analysis page.